Home › Funds › EcoR1 Capital, LLC › CGON

EcoR1 Capital, LLC position in CGON

CG ONCOLOGY INC · Health Care

EcoR1 Capital, LLC reported holding 561,500 shares of CGON (CG ONCOLOGY INC) in its Q2 2026 13F filing — a position valued at US$39.9M, representing 2.05% of its reported portfolio and ranking #10 among its reported holdings. EcoR1 Capital, LLC has disclosed CGON holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)561.50K sh
Reported value held$39.89M
Portfolio Weight2.05%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EcoR1 Capital, LLC's CGON position evolved

EcoR1 Capital, LLC first disclosed a stake in CGON in Q4 2025 at 292,800 shares (US$12.2M). The position peaked in Q1 2026 at 1,102,000 shares, worth US$74.6M. Across 3 filings, EcoR1 Capital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 561,500 shares valued at US$39.9M — a reduction of -540,500 shares quarter over quarter.. Notable position changes include a 276% increase in Q1 2026 (shares rose 5% over the following quarter), a 49% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 292.80K $12.16M New
Q1 2026 1.10M $74.58M Add
Q2 2026 561.50K $39.89M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CGON and 13F data

CGON (CG ONCOLOGY INC) is a Health Care company. 52 other funds we track also report a position in CGON — the largest reported positions include RTW INVESTMENTS, LP (US$605.0M), Decheng Capital LLC (US$452.7M), TCG Crossover Management, LLC (US$260.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CGON

All CGON fund holders →

FAQ

How long has EcoR1 Capital, LLC held CGON?

EcoR1 Capital, LLC has disclosed CGON holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is EcoR1 Capital, LLC's current position in CGON?

As of Q2 2026, EcoR1 Capital, LLC holds 561.50K shares of CGON (CG ONCOLOGY INC), valued at $39.89M, representing 2.05% of its reported portfolio and ranking #10.

Has EcoR1 Capital, LLC been buying or selling CGON?

In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC reduced its position in CGON. The position peaked in Q1 2026 at 1.10M shares.

Which other funds hold CGON?

Other major institutional holders of CGON include RTW INVESTMENTS, LP, Decheng Capital LLC, TCG Crossover Management, LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.